155
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Ordered mesoporous silica material SBA-15: loading of new calcium channel blocker – lacidipine

, , &
Pages 21-27 | Received 17 Jan 2012, Accepted 16 Apr 2012, Published online: 07 Jun 2012

References

  • Bayomi MA, Abanumay KA, Al-Angary AA. Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state. Inter J Pharm 2002; 43: 107–17
  • Carpi C, Gaviraghi G, Semeraro C. GX 1048 (GR 43659X), a new dihydropyridine calcium antagonist with potent and long–lasting antihypertensive action. Br J Pharmacol 1986; 89: 758P
  • Chan KLA, Fleming OS, Kazarian SG, Vassou D, Chryssikos GD, Gionis V. Polymorphism and devitrification of nifedipine under controlled humidity: A combined FT-Raman, IR and Raman microscopic investigation. J Raman Spectrosc 2004; 35: 353–9
  • Doadrio AL, Sousa EM, Doadrio JC, Perez J, Pariente J, Izquierdo-Barba I, Vallet-Regi M. Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. J. Controlled Release 2004; 97: 125–32
  • Hata H, Saeki S, Kimura T, Sugahara Y, Kuroda K. Adsorption of taxol into ordered mesoporous silicas with various pore diameters. Chem Mater 1999; 11: 1110–19
  • Heikkila T, Salonen J, Tuura J, Kumar N, Salmi T, Murzin DY, Hamdy MS, Mul G, Laitinen L, Kaukonen AM, et al. Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery. Drug Deliv 2007; 14: 337–47
  • IUPAC. Recommendations for the characterization of porous solids. Pure Appl Chem 1994; 66: 1739–58
  • Karger BL, Snyder LR, Eon C. Expanded solubility parameter treatment for classification and use of chromatographic solvents and adsorbents. Anal Chem 1978; 50: 2126–36
  • Kim TW, Slowing II, Chung PW, Lin VS. Ordered mesoporous polymer-silica hybrid nanoparticles as vehicles for the intracellular controlled release of macromolecules. Acs Nano 2011; 5: 360–6
  • Lee JW, Tra PT, Kim SI, Roh SH. Adsorption properties of proteins on SBA-15 nanoparticles functionalized with aminosilanes. J Nanosci Nanotech 2008; 8: 5152–7
  • Lopez T, Ortiz E, Alexander-Katz R, Basaldella E, Bokhimi X. Cortisol controlled release by mesoporous silica. Nanomedicine 2009; 5: 170–7
  • Mellaerts R, Aerts CA, van Humbeeck J, Augustijns P, van den Mooter G, Martens JA. Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials. Chem Commun 2007; 13: 1375–7
  • Mellaerts R, Jammaer JA, van Speybroeck M, Chen H, van Humbeeck J, Augustijns P, van den Mooter P, Martens JA. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: A case study with itraconazole and ibuprofen. Langmuir 2008; 24: 8651–9
  • Perez-Quintanilla D, Gomez-Ruiz S, Zizak Z, Sierra I, Prashar S, Del Hierro I, Fajardo M, Juranic ZD, Kaluderovic GN. A new generation of anticancer drugs: Mesoporous materials modified with titanocene complexes. Chem-A Eur J 2009; 15: 5588–97
  • Raju VV, Ravindra V, Mathad VT, Dubey PK, Reddy PP. A facile, one-pot synthesis of lacidipine using in situ generation of wittig intermediates. Org Process Res Dev 2009; 13: 710–15
  • Shen S, Chow PS, Chen F, Tan RB. Submicron particles of SBA-15 modified with MgO as carriers for controlled drug delivery. Chem Pharm Bull 2007; 55: 985–91
  • Shir IB, Kababya S, Amitay-Rosen T, Balazs YS, Schmidt A. Molecular level characterization of the inorganic-bioorganic interface by solid state NMR: Alanine on a silica surface, a case study. J Phys Chem B 2010; 114: 5989–96
  • Song SW, Hidajat K, Kawi S. Functionalized SBA-15 materials as carriers for controlled drug delivery: Influence of surface properties on matrix-drug interactions. Langmuir 2005; 21: 9568–75
  • Song SW, Hidajat K, Kawi S. pH-Controllable drug release using hydrogel encapsulated mesoporous silica. Chem Commun 2007; 42: 4396–8
  • Tao Z, Toms B, Goodisman J, Asefa T. Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs. Acs Nano 2010a; 4: 789–94
  • Tao Z, Xie Y, Goodisman J, Asefa T. Isomer-dependent adsorption and release of cis- and trans-platin anticancer drugs by mesoporous silica nanoparticles. Langmuir 2010b; 26: 8914–24
  • Tian BS, Yang C. Thermo-sensitive poly(N-isopropylacrylamide)/mesoporous silica nanocomposites as controlled delivery carriers: Loading and release behaviors for drug ibuprofen. J Nanosci Nanotech 2011; 11: 1871–9
  • Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007; 46: 7548–58
  • Vallet-Regi M, Manzano M, Gonzalez-Calbet JM, Okunishi E. Evidence of drug confinement into silica mesoporous matrices by STEM spherical aberration corrected microscopy. Chem Commun 2010; 46: 2956–8
  • Wanka G, Hofmann H, Ulbriht W. Phase diagrams and aggregation behavior of Poly(oxyethy1ene)-Poly(oxypropylene)-Poly(oxyethylene) triblock copolymers in aqueous solutions. Macromolecules 1994; 27: 4145–59
  • Wang X, Wang P, Dong Z, Dong Z, Ma Z, Jiang J, Li R, Ma J. Sensitive fluorescence probe based on functional SBA-15 for selective detection of Hg2+. Nanoscale Res Lett 2010; 5: 1468–73
  • Yu H, Zhai Q. Mesoporous SBA-15 molecular sieve as a carrier for controlled release of nimodipine. Micropor Mesopor Mat 2009; 123: 298–305
  • Zhao D, Feng J, Huo Q, Melosh N, Fredrickson GH, Cmelka BF, Stucky GD. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 1998; 279: 548–52
  • Zonouz AM, Moghani D. Synthesis of 1,4-dihydropyridine derivatives under solvent-free and grinding conditions. Synthetic Commun 2011; 41: 2152–60

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.